2020 update to CEAP classification system and reporting ...

A 2020 update on the Clinical-Etiology-Anatomy-Pathophysiology (CEAP) classification system and reporting standards, authored by Fedor Lurie ... Home LatestNews Features VascularNews Profiles Media Videos Podcasts Events Supplements PastIssues Subscriptions Search VenousNews Home LatestNews Features VascularNews Profiles Media Videos Podcasts Events Supplements PastIssues Subscriptions LatestNews FedorLurie A2020updateontheClinical-Etiology-Anatomy-Pathophysiology(CEAP)classificationsystemandreportingstandards,authoredbyFedorLurie(JobstVascularInstitute,Toledo,USA;UniversityofMichigan,AnnArbor,USA)andcolleagues,hasbeenpublishedintheJournalVascularSurgery:VenousandLymphaticDisorders. LurieetalbeginbydescribingtheCEAPclassificationasaninternationallyacceptedstandardfordescribingpatientswithchronicvenousdisordersandexplainthatithasbeenusedforreportingclinicalresearchfindingsinscientificjournals. Theyelaborate:“Developedin1993,updatedin1996,andrevisedin2004,CEAPisaclassificationsystembasedonclinicalmanifestationsofchronicvenousdisorders,oncurrentunderstandingoftheetiology,theinvolvedanatomy,andtheunderlyingvenouspathology.” Theauthorsexplainthat,astheevidencerelatedtotheseaspectsofvenousdisorders,andspecificallyofchronicvenousdiseases(CVD,C2–C6)continuetodevelop,theCEAPclassificationneedsperiodicanalysisandrevisions. InMay2017,theAmericanVenousForum(AVF)createdaCEAPTaskForceandchargedittocriticallyanalysisthecurrentclassificationsystemandrecommendedrevisionswhereneeded. Guidedbyfourbasicprinciples—preservationofthereproducibilityofCEAP,compatibilitywithpriorversions,evidence-based,andpracticalguidanceforclinicaluse—theTaskForcehasadoptedtherevisedDelphiprocessandmadeseveralchanges. TheseincludeaddingCoronaphlebectaticaastheC4cclinicalsubclass,introducingthemodifier“r”forrecurrentvaricoseveinsandrecurrentvenousulcers,andreplacingnumericdescriptionsofthevenoussegmentsbytheircommonabbreviations. Theauthorsnotethat,sinceitsinitialdevelopment,theCEAPclassificationhasbeenandcontinuestobe“animportantcontributortoprogressinthefieldofCVD.Ithasbecomeauniversallyacceptedstandardinresearchandreporting.” Althoughthestabilityofclassificationis“essential”formaintainingscientificandclinicaladvancement,“continuouslyaccumulatedevidenceandknowledgerequirerevisitingtheclassificationanditsdefinitionsandrevisingthemwhennecessary,”theyremark. Lurieetalconclude:“This2020CEAPrevisionisaresultofarigorousprocessofevidenceanalysis.Althoughseveralproposedchangeswerenotincludedinthefinalversion,proponentsoftheseandotherfuturepotentialrevisionsareencouragedtodevelopandpublishsupportingevidence.Whensuchevidenceisavailable,theAVFTaskForcewillrevisittheCEAPclassificationsystem,makingrevisionsaspartofacontinualprocessandmaintainingtheintegrityofCEAPastheuniversallyacceptedclassificationsystemandreportingstandardforCVD.” Inanaccompanyingeditorial,BoEklöf(LundUniversity,Helsingborg,Sweden)laudsthe“timelyandwarranted”revisionofthe25-yearoldCEAPclassification,notingthat“reliancefortoolongwasplacedontheclinicalappearanceofthelimbandthesuperficialveins,withoutrequiringobjectivetestingofthevenoussystemtosubstantiatethediagnosis.” Heelaborates:“PreviousclassificationsfromWidmer(1978)throughMiranda(1993)lackedcompletenessandobjectivityneededforscientificaccuracy.” Focusingonthe2020update,Eklöfcomments:“TheAVFTaskForce,undertheleadershipinFedorLurieandMarkPassman[UniversityofAlabamaatBirmingham,Birmingham,USA],hasdoneanexcellentjobwiththelatest,secondrevisionandwithexplanationoftheimportantroleofCEAPinCVD.” “PublicationofthedocumentappearstobeagoodreasontoremindreviewersandeditorstorequirethecompleteCEAP—basicoradvanced—classificationformanuscriptsdealingwithCVDtoimprovethescientificqualityofpublishedliterature.Bybothadheringtotheseprinciples,wemaybebackwherewewere40yearsago,usingWidmer’sclinicalclassification.”Previouslyintheeditorial,EklöfremarksthatWidmer’sclassification(1978)“lackedcompletenessandobjectivityneededforscientificaccuracy”. RELATEDARTICLESMOREFROMAUTHOR AVF2022:Emergingautogenousvenousvalveformationsystemsees“continualimprovement” AVF2022:Six-monthCLOUTdataindicateClotTrievercaneffectivelyremovefullspectrumofthrombus AVF2022:VenoValveimprovement‘maintained’for2.5yearswithoutadverseevents LEAVEAREPLYCancelreply Pleaseenteryourcomment! Pleaseenteryournamehere Youhaveenteredanincorrectemailaddress! Pleaseenteryouremailaddresshere Δ  Mostreadinpast7days  CX2020LIVEaddresseslatestdevelopmentsinsuperficialvenousdisease 8thJune2020 CardiovascularSystemspartnerswithInnovaVasculartodevelopfulllineof... 25thFebruary2022 Systematicreviewdeemsablationofsuperficialvenousrefluxsafeforpatients... 21stFebruary2022  Features  CX2022venousandlymphaticchallenges:“Weareataturning... 2ndMarch2022 CXreturnstoin-personformatoncemoreintheLondonspring 28thFebruary2022 ESVSCVDguidelinewritingcommittee“entirelyrenewsstructure”ofrecommendations 13thJanuary2022  Profiles  RaghuKolluri 22ndJanuary2020 JohnKaufman 21stNovember2019 KuroshParsi 8thOctober2019     TweetsbyVenousNews Writetous Editor:[email protected] Advertising:[email protected] UnitedKingdom: BIBAMedical,Europe526FulhamRoad,Fulham,London,SW65NR TEL:+44(0)2077368788 Email:[email protected] UnitedStates: BIBAMedical,NorthAmerica 155NorthWackerDrive,Suite4250,Chicago,IL60606 TEL:+19497239309 Email:[email protected] TermsandConditions|PrivacyPolicy